insights_auto
Why is ORX down 4,01%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
1,39 SEK
arrow_downward
-4,01%(-0,058) 1D
5-ноя., 17:29:49 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,34 SEK
High
1,55 SEK
Low
1,34 SEK
Mkt. cap
48,76 млн
Avg. vol.
305,99 миң
Volume
454,56 миң
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
1,34 SEK
High
1,55 SEK
Low
1,34 SEK
Mkt. cap
48,76 млн
Avg. vol.
305,99 миң
Volume
454,56 миң
P/E ratio
0,06
52-wk high
36,00 SEK
52-wk low
1,30 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
The Motley Fool
·
1 саат мурун
The Nasdaq Plunges 5%. What the Data Center Crash Means for Investors
Forbes
·
53 мүнөт мурун
Hidden Risk In The SP 500: When Diversification Becomes An Illusion
Seeking Alpha
·
14 мүнөт мурун
Market Swims In A Sea Of Red
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com